Wednesday, December 8, 2010

Sequenta Raises $13M

San Francisco-based Sequenta, a developer of a molecular diagnostics platform focused on immune system profiling, said today that it has raised $13M in a Series B funding round. The round came from Index Ventures, Mohr Davidow Ventures, and individual investor Jacob Goldfield. Sequenta said the funds will go towards development and commercialization of its products. More information »